MTTRIHPWClinical Validation of ASTN1, DLX1, ITGA4, RXFP3, SOX17, ZNF671 Methylation in HPV Positive Women: a Multi-center RCT From China

This study focuses on the clinical validation of certain genetic markers in women who have tested positive for HPV, the virus often associated with cervical cancer. The research aims to determine if these specific markers can help better predict the progression to more severe cervical conditions. This is particularly important for women who might be at risk of developing significant cervical changes, as it could lead to earlier and more precise interventions, ultimately improving their health outcomes. The study is conducted in two phases: an initial phase and a follow-up phase after one year. Participants undergo a series of tests, including checking for HPV, cellular changes through cytology, and genetic marker methylation tests. If initial tests show significant changes, participants may undergo more detailed examination through colposcopy and biopsy. However, if there are no concerning findings, participants continue with follow-up testing at six months and one year. The study does not mention specific risks, but ongoing monitoring ensures that any potential progression of the disease is detected early.